Overall, vaccinia VG9/(SST-14)2-HSA, which has both the oncolytic effect of the virus and the anti-tumor effect of (SST-14)2-HSA, is a promising anti-tumor agent for virotherapy. The gene discussed is ALB; the disease is neoplasm.